• Skip to primary navigation
  • Skip to main content

Yamo Pharmaceuticals

Cutting Edge Pharmaceutial Technologies

  • About Us
    • Company Overview
    • Our Team
    • Scientific Advisory Board
  • Our Technology
    • Yamo’s Treatment for Autism
    • About Autism
  • Information for Patients and Caregivers
    • Future Clinical Studies
    • Compassionate Use Policy
  • News & Publications
  • Contact Us
    • General Inquiries
    • Participation in Future Clinical Studies

Eugene Prahin

Chief Financial Officer

  • Since 2008, Mr. Prahin has been with Columbus Nova, a multi-strategy investment firm, as the Chief Operating Officer, with responsibilities including operations, planning and analysis, management reporting, performance analysis, investor relations and investment management
  • From 2005 to 2008, he was a Manager in the Structured Finance Group of GSC Group where he built and managed the Group’s operations
  • Prior to his MBA, Mr. Prahin worked with the Fixed Income Derivatives Group at Lehman Brothers
  • Mr. Prahin holds an MBA from the London Business School (2005) and a B.Sc. in management, with a focus in finance and international business, from the State University of New York at Binghamton (1998)
  • Copyright © 2025 Yamo Pharmaceuticals
  • Terms and Conditions
  • Privacy Policy